Breaking News on Supplements & Nutrition - North America EU edition
News Headlines
On your radar
All news articles
Product news
Health condition news
Product Innovations
product news
Antioxidants, carotenoids
Cosmeceuticals
Dairy-based ingredients
Dosage forms
Fibers and carbohydrates
Minerals
Nutritional lipids and oils
Phytochemicals, plant extracts
Probiotics and prebiotics
Proteins, peptides, amino acids
Soy-based ingredients
Vitamins & premixes
product innovations
All products
Sponsored Webinars
Videos & Audio
Technical & Research papers
Products, Brochures, Web links
Supplier Info Centers
Product innovations > Clinical Study
Fill form to download now!
The Safety of OptiMSM®: A Clinical Review
Healthy joints are essential to the enjoyment of life, and for years, MSM has been helping. OptiMSM®, the purest form of MSM available, is the only brand backed by published, peer-reviewed safety research.
After years of extensive testing on animal and human subjects, OptiMSM® continues to receive high marks for safety. Numerous studies have shown little to no adverse effects, regardless of dose. Additionally, MSM has proven beneficial for immune and respiratory functions, as well as the circulatory system, with no recorded interactions with other pharmaceutical or nutraceutical agents.
|
|
Related topics:
Related sites
All Decision News Media Sites
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
